ProChoice H-PR Aid Capsules.
Natural health product licensed in Canada
- Other names
- ProChoice ProCardio Capsules
- Licence holder
- ProChoice Herbals
- NPN or DIN-HM
- 80042914
- Status
- Active licence
- Licence date
- 18 June 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Leonurus cardiaca L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les femmes enceintes
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Piscidia piscipula Source : Écorce de racine | 100 mg | Not calculated |
| Magnésium Source : Oxyde de magnésium | 50 mg | 150,000 µg |
| Crataegus laevigata Source : Fruit Extraction ratio : 10:1 Dry plant equivalent : 50 mg | 5 mg | Not calculated |
| Leonurus cardiaca Source : Plante entière | 50 mg | Not calculated |
| Urtica dioica Source : Racine Extract : Extract Type TBA Extraction ratio : 10:1 Dry plant equivalent : 25 mg | 2.5 mg | Not calculated |
| Taraxacum officinale Source : root wood Extract : Extract Type TBA Extraction ratio : 10:1 Dry plant equivalent : 25 mg | 2.5 mg | Not calculated |
| Polygala senega Source : Racine | 250 mg | Not calculated |
Non-medicinal ingredients
Gélatine, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to help maintain cardiovascular health in adults.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity (e.g. allergy) has been known to occur; in which case discontinue use. Discontinue use if diarrhea, stomach irritation, and/or uterine bleeding occurs. Consumption with pain killers, alcohol or other medications and natural health products with sedative properties is not recommended. Some people may experience drowsiness. Exercise caution if operating heavy machinery or driving a motor vehicle or involved in activities requiring mental alertness. Discontinue use if you experience vomiting, nausea or headache.
Source
Official Health Canada record, licence 80042914
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.